Applied Therapeutics enters $75M at-the-market equity facility with Cantor Fitzgerald

Applied Therapeutics, Inc.

At-the-market offering of up to $75M in common stock; agent commission 3% of gross proceeds.
Prior Leerink Partners ATM facility terminated effective Aug 29, 2025.
Under Leerink facility (Aug 2023–Aug 2025), sold 20.6M shares for net proceeds of ~$49.3M.
Company has no obligation to sell; Cantor not required to sell any specific amount.

item 1.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.